Contact
searchSearch
HMP Global

Advertisement

Meet the Experts

headshot of Doug Devens Doug Devens
headshot of Kris Flinn Kris Flinn
Headshot of Terry Hayslett Terry Hayslett
Headshot of Susan Paquette Susan Paquette
headshot of Lennart Stalder Lennart Stadler
Headshot of Anikó Szekér Anikó Szekér

 

Click here to learn more

SmartTrak x Wound Care Collaboration

Featured Commentaries

Skin Substitute Market Rocked by DOJ Investigations
Blog
Skin Substitute Market Rocked by DOJ Investigations
08/08/2024
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions...
08/08/2024
Wound Care
SAWC Spring 2024: Highlighting the Hot Topic of Skin Substitute Reimbursement
Blog
SAWC Spring 2024: Highlighting the Hot Topic of Skin Substitute Reimbursement
06/12/2024
This blog was originally posted on SmartTrak's website on June 19, 2024: https://blog.smarttrak.com/sawc-spring-2024-highlighting-the-hot-topic-of-skin-substitute-reimbursement. Reposted with permission. The proposed MAC LCDs for...
This blog was originally posted on SmartTrak's website on June 19, 2024: https://blog.smarttrak.com/sawc-spring-2024-highlighting-the-hot-topic-of-skin-substitute-reimbursement. Reposted with permission. The proposed MAC LCDs for...
This blog was originally...
06/12/2024
Wound Care
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
Blog
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
05/29/2024
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united...
05/29/2024
Wound Care
Vaporox Company Spotlight
Blog
Vaporox Company Spotlight
05/07/2024
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally...
05/07/2024
Wound Care
Swedish Wound Care Companies – You Win Some, You Lose Some
Blog
Swedish Wound Care Companies – You Win Some, You Lose Some
04/10/2024
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally...
04/10/2024
Wound Care
Preview Image
Blog
What Impact will GLP-1 Agonists have on Chronic Wounds?
03/18/2024
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1...
03/18/2024
Wound Care
Preview Image
Partner Content
Advanced Wound Dressings: 2024 Market Outlook
03/05/2024
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW...
03/05/2024
Wound Care
Wound Debridement 2024 Outlook
Partner Content
Wound Debridement 2024 Outlook
02/12/2024

SmartTRAK

SmartTRAK
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care...
02/12/2024
Wound Care
The Past, Present and Future of 3M Health Care
Partner Content
The Past, Present and Future of 3M Health Care
01/29/2024

SmartTRAK

SmartTRAK
SmartTRAK looks back at the evolution of 3M Health Care, its businesses today, the entry into Advanced Wound Care (AWC) and potential new opportunities for the new Health Care business.
SmartTRAK looks back at the evolution of 3M Health Care, its businesses today, the entry into Advanced Wound Care (AWC) and potential new opportunities for the new Health Care business.
SmartTRAK looks back at the...
01/29/2024
Wound Care
SAWC Fall 2023: Skin Substitutes Reign Again
Partner Content
SAWC Fall 2023: Skin Substitutes Reign Again
01/04/2024

SmartTRAK

SmartTRAK
SmartTRAK highlights the latest news from SAWC Fall 2023 for the ever-changing, continually growing skin substitute/CTP segment.
SmartTRAK highlights the latest news from SAWC Fall 2023 for the ever-changing, continually growing skin substitute/CTP segment.
SmartTRAK highlights the latest...
01/04/2024
Wound Care
Skin Substitute Market Rocked by DOJ Investigations
Blog
Skin Substitute Market Rocked by DOJ Investigations
08/08/2024
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions...
08/08/2024
Wound Care
SAWC Spring 2024: Highlighting the Hot Topic of Skin Substitute Reimbursement
Blog
SAWC Spring 2024: Highlighting the Hot Topic of Skin Substitute Reimbursement
06/12/2024
This blog was originally posted on SmartTrak's website on June 19, 2024: https://blog.smarttrak.com/sawc-spring-2024-highlighting-the-hot-topic-of-skin-substitute-reimbursement. Reposted with permission. The proposed MAC LCDs for...
This blog was originally posted on SmartTrak's website on June 19, 2024: https://blog.smarttrak.com/sawc-spring-2024-highlighting-the-hot-topic-of-skin-substitute-reimbursement. Reposted with permission. The proposed MAC LCDs for...
This blog was originally...
06/12/2024
Wound Care
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
Blog
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
05/29/2024
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united...
05/29/2024
Wound Care
Vaporox Company Spotlight
Blog
Vaporox Company Spotlight
05/07/2024
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally...
05/07/2024
Wound Care
Swedish Wound Care Companies – You Win Some, You Lose Some
Blog
Swedish Wound Care Companies – You Win Some, You Lose Some
04/10/2024
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally...
04/10/2024
Wound Care
Preview Image
Blog
What Impact will GLP-1 Agonists have on Chronic Wounds?
03/18/2024
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1...
03/18/2024
Wound Care
Preview Image
Partner Content
Advanced Wound Dressings: 2024 Market Outlook
03/05/2024
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW...
03/05/2024
Wound Care
Wound Debridement 2024 Outlook
Partner Content
Wound Debridement 2024 Outlook
02/12/2024

SmartTRAK

SmartTRAK
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care...
02/12/2024
Wound Care
The Past, Present and Future of 3M Health Care
Partner Content
The Past, Present and Future of 3M Health Care
01/29/2024

SmartTRAK

SmartTRAK
SmartTRAK looks back at the evolution of 3M Health Care, its businesses today, the entry into Advanced Wound Care (AWC) and potential new opportunities for the new Health Care business.
SmartTRAK looks back at the evolution of 3M Health Care, its businesses today, the entry into Advanced Wound Care (AWC) and potential new opportunities for the new Health Care business.
SmartTRAK looks back at the...
01/29/2024
Wound Care
SAWC Fall 2023: Skin Substitutes Reign Again
Partner Content
SAWC Fall 2023: Skin Substitutes Reign Again
01/04/2024

SmartTRAK

SmartTRAK
SmartTRAK highlights the latest news from SAWC Fall 2023 for the ever-changing, continually growing skin substitute/CTP segment.
SmartTRAK highlights the latest news from SAWC Fall 2023 for the ever-changing, continually growing skin substitute/CTP segment.
SmartTRAK highlights the latest...
01/04/2024
Wound Care

SmartTRAK Wound Market Analyses

August 5: According to SmartTRAK analysis, the WW Short-Stretch Bandages market is estimated to have a 5-year CAGR of +5.8%. It is the fastest growing sub-segment in compression and is led by Hartmann Group with 28.4% share.

July 29: According to SmartTRAK analysis, Topical Drug/Delivery products are expected to grow with a 5-yr CAGR of +3.2%, due to low single-digit growth of Smith+Nephew’s Santyl, which dominates the segment, and also the emergence of new entrants.

For more market analyses, click here.

Wound Care Updates

News
Avita Medical
08/08/2024
Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by...
Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by...
Avita enters into an exclusive...
08/08/2024
Wound Care
News
MiMedx Group 
08/08/2024
MiMedx announces the launch of its first xenograft product, HELIOGEN, a particulate fibrillar bovine collagen matrix for addressing complex wounds primarily in the surgical setting.
MiMedx announces the launch of its first xenograft product, HELIOGEN, a particulate fibrillar bovine collagen matrix for addressing complex wounds primarily in the surgical setting.
MiMedx announces the launch of...
08/08/2024
Wound Care
News
Polaroid Therapeutics 
08/08/2024
Polaroid Therapeutics announced its partnership with Speciality Fibres and Materials Ltd to test a novel wound dressing that prevents infection and aids healing. The trials aim to create a breakthrough in advanced wound care, particularly for...
Polaroid Therapeutics announced its partnership with Speciality Fibres and Materials Ltd to test a novel wound dressing that prevents infection and aids healing. The trials aim to create a breakthrough in advanced wound care, particularly for...
Polaroid Therapeutics announced...
08/08/2024
Wound Care
News
MiMedx Group 
08/08/2024
MiMedx management noted that the increase in revenue was partially offset by commercial challenges due to sales of artificially high-priced skin substitute products by competitors, the uncertainty of Medicare reimbursements and sales team...
MiMedx management noted that the increase in revenue was partially offset by commercial challenges due to sales of artificially high-priced skin substitute products by competitors, the uncertainty of Medicare reimbursements and sales team...
MiMedx management noted that the...
08/08/2024
Wound Care
News
EscharEx - MediWound 
08/08/2024
Results of a 196-patient RCT comparing the efficacy of ExcharEx for debridement of VLUs vs placebo (GV) and nonsurgical SoC (NSSOC) showed a significantly higher incidence of complete debridement at 63% compared to GV (30.2%) and NSSOC (13%),...
Results of a 196-patient RCT comparing the efficacy of ExcharEx for debridement of VLUs vs placebo (GV) and nonsurgical SoC (NSSOC) showed a significantly higher incidence of complete debridement at 63% compared to GV (30.2%) and NSSOC (13%),...
Results of a 196-patient RCT...
08/08/2024
Wound Care
News
AOTI
08/08/2024
AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k)...
08/08/2024
Wound Care
News
Integra
08/08/2024
Integra announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, Massachusetts in H126. IART also noted it expects Integra Skin sales to be at normalized run rates during Q424. IART...
Integra announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, Massachusetts in H126. IART also noted it expects Integra Skin sales to be at normalized run rates during Q424. IART...
Integra announced plans to...
08/08/2024
Wound Care
News
Convatec
08/08/2024
In H224, Convatec expects to further grow sales of InnovaMatrix by pursuing other indications and by starting the launch of InnovaMatrix outside of the US. In addition, RCT’s are to be initiated for VLUs and DFUs in Q324. CTEC H124 Earnings...
In H224, Convatec expects to further grow sales of InnovaMatrix by pursuing other indications and by starting the launch of InnovaMatrix outside of the US. In addition, RCT’s are to be initiated for VLUs and DFUs in Q324. CTEC H124 Earnings...
In H224, Convatec expects to...
08/08/2024
Wound Care
News
AmnioWrap2 - BioStem Technologies
07/30/2024
BioStem Technologies initiated a 60-patient RCT to evaluate the safety and efficacy of AmnioWrap2 plus SoC vs SoC only for treatment of DFUs with primary outcome of % of wound closure over 12 weeks. Not yet recruiting; estimated study...
BioStem Technologies initiated a 60-patient RCT to evaluate the safety and efficacy of AmnioWrap2 plus SoC vs SoC only for treatment of DFUs with primary outcome of % of wound closure over 12 weeks. Not yet recruiting; estimated study...
BioStem Technologies initiated a...
07/30/2024
Wound Care
News
Surgenex
07/30/2024
Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with...
Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with...
Surgenex has initiated a...
07/30/2024
Wound Care
News
Avita Medical
08/08/2024
Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by...
Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by...
Avita enters into an exclusive...
08/08/2024
Wound Care
News
MiMedx Group 
08/08/2024
MiMedx announces the launch of its first xenograft product, HELIOGEN, a particulate fibrillar bovine collagen matrix for addressing complex wounds primarily in the surgical setting.
MiMedx announces the launch of its first xenograft product, HELIOGEN, a particulate fibrillar bovine collagen matrix for addressing complex wounds primarily in the surgical setting.
MiMedx announces the launch of...
08/08/2024
Wound Care
News
Polaroid Therapeutics 
08/08/2024
Polaroid Therapeutics announced its partnership with Speciality Fibres and Materials Ltd to test a novel wound dressing that prevents infection and aids healing. The trials aim to create a breakthrough in advanced wound care, particularly for...
Polaroid Therapeutics announced its partnership with Speciality Fibres and Materials Ltd to test a novel wound dressing that prevents infection and aids healing. The trials aim to create a breakthrough in advanced wound care, particularly for...
Polaroid Therapeutics announced...
08/08/2024
Wound Care
News
MiMedx Group 
08/08/2024
MiMedx management noted that the increase in revenue was partially offset by commercial challenges due to sales of artificially high-priced skin substitute products by competitors, the uncertainty of Medicare reimbursements and sales team...
MiMedx management noted that the increase in revenue was partially offset by commercial challenges due to sales of artificially high-priced skin substitute products by competitors, the uncertainty of Medicare reimbursements and sales team...
MiMedx management noted that the...
08/08/2024
Wound Care
News
EscharEx - MediWound 
08/08/2024
Results of a 196-patient RCT comparing the efficacy of ExcharEx for debridement of VLUs vs placebo (GV) and nonsurgical SoC (NSSOC) showed a significantly higher incidence of complete debridement at 63% compared to GV (30.2%) and NSSOC (13%),...
Results of a 196-patient RCT comparing the efficacy of ExcharEx for debridement of VLUs vs placebo (GV) and nonsurgical SoC (NSSOC) showed a significantly higher incidence of complete debridement at 63% compared to GV (30.2%) and NSSOC (13%),...
Results of a 196-patient RCT...
08/08/2024
Wound Care
News
AOTI
08/08/2024
AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k)...
08/08/2024
Wound Care
News
Integra
08/08/2024
Integra announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, Massachusetts in H126. IART also noted it expects Integra Skin sales to be at normalized run rates during Q424. IART...
Integra announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, Massachusetts in H126. IART also noted it expects Integra Skin sales to be at normalized run rates during Q424. IART...
Integra announced plans to...
08/08/2024
Wound Care
News
Convatec
08/08/2024
In H224, Convatec expects to further grow sales of InnovaMatrix by pursuing other indications and by starting the launch of InnovaMatrix outside of the US. In addition, RCT’s are to be initiated for VLUs and DFUs in Q324. CTEC H124 Earnings...
In H224, Convatec expects to further grow sales of InnovaMatrix by pursuing other indications and by starting the launch of InnovaMatrix outside of the US. In addition, RCT’s are to be initiated for VLUs and DFUs in Q324. CTEC H124 Earnings...
In H224, Convatec expects to...
08/08/2024
Wound Care
News
AmnioWrap2 - BioStem Technologies
07/30/2024
BioStem Technologies initiated a 60-patient RCT to evaluate the safety and efficacy of AmnioWrap2 plus SoC vs SoC only for treatment of DFUs with primary outcome of % of wound closure over 12 weeks. Not yet recruiting; estimated study...
BioStem Technologies initiated a 60-patient RCT to evaluate the safety and efficacy of AmnioWrap2 plus SoC vs SoC only for treatment of DFUs with primary outcome of % of wound closure over 12 weeks. Not yet recruiting; estimated study...
BioStem Technologies initiated a...
07/30/2024
Wound Care
News
Surgenex
07/30/2024
Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with...
Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with...
Surgenex has initiated a...
07/30/2024
Wound Care

About This Partnership

Wound Care Learning Network has partnered with SmartTRAK, the global leader in business intelligence for the life sciences industry, to provide market data and analyses in wound care.  Through rich ongoing updates and comprehensive expert analyses, wound care professionals will stay ahead of evolving market trends and conditions of interest to the wound care community.

For more information on SmartTRAK resources and services, click here.

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement